Global Macular Degeneration (Amd) And Other Retinal Diseases Market Research Report 2026(Status and Outlook)
Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands.
The global Macular Degeneration (Amd) And Other Retinal Diseases market size was estimated at USD 18850.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Macular Degeneration (Amd) And Other Retinal Diseases market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Macular Degeneration (Amd) And Other Retinal Diseases market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Macular Degeneration (Amd) And Other Retinal Diseases market.
Global Macular Degeneration (Amd) And Other Retinal Diseases Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC
Market Segmentation (by Type)
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy(DR)
Retinal Vein Occlusion
Wet Age-Related Macular Degeneration (wAMD)
Dry Age-Related Macular Degeneration (dAMD)
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Macular Degeneration (Amd) And Other Retinal Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Macular Degeneration (Amd) And Other Retinal Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Macular Degeneration (Amd) And Other Retinal Diseases market size was estimated at USD 18850.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Macular Degeneration (Amd) And Other Retinal Diseases market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Macular Degeneration (Amd) And Other Retinal Diseases market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Macular Degeneration (Amd) And Other Retinal Diseases market.
Global Macular Degeneration (Amd) And Other Retinal Diseases Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
Merck
Allergan
Santen Pharmaceutical
GlaxoSmithKline Pharmaceuticals
Pfizer
Acucela
Valent Pharmaceuticals
IVERIC
Market Segmentation (by Type)
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy(DR)
Retinal Vein Occlusion
Wet Age-Related Macular Degeneration (wAMD)
Dry Age-Related Macular Degeneration (dAMD)
Other
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Macular Degeneration (Amd) And Other Retinal Diseases Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Macular Degeneration (Amd) And Other Retinal Diseases Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Macular Degeneration (Amd) And Other Retinal Diseases, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Macular Degeneration (Amd) And Other Retinal Diseases
1.2 Key Market Segments
1.2.1 Macular Degeneration (Amd) And Other Retinal Diseases Segment by Type
1.2.2 Macular Degeneration (Amd) And Other Retinal Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Product Life Cycle
3.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Manufacturers (2020-2025)
3.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Macular Degeneration (Amd) And Other Retinal Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Macular Degeneration (Amd) And Other Retinal Diseases Market Competitive Situation and Trends
3.8.1 Macular Degeneration (Amd) And Other Retinal Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest Macular Degeneration (Amd) And Other Retinal Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES INDUSTRY CHAIN ANALYSIS
4.1 Macular Degeneration (Amd) And Other Retinal Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Macular Degeneration (Amd) And Other Retinal Diseases Market
5.7 ESG Ratings of Leading Companies
6 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Type (2020-2025)
6.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (2020-2025)
6.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Price by Type (2020-2025)
7 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Sales by Application (2020-2025)
7.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) by Application (2020-2025)
7.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
8 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SALES BY REGION
8.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.1.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region
8.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.2.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.2.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.3 North America
8.3.1 North America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.3.2 North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.4.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.5.2 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.6.2 South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.7.2 Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET PRODUCTION BY REGION
9.1 Global Production of Macular Degeneration (Amd) And Other Retinal Diseases by Region(2020-2025)
9.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Region (2020-2025)
9.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Macular Degeneration (Amd) And Other Retinal Diseases Production
9.4.1 North America Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.4.2 North America Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production
9.5.1 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.5.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (2020-2025)
9.6.1 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.6.2 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Macular Degeneration (Amd) And Other Retinal Diseases Production (2020-2025)
9.7.1 China Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.7.2 China Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Regeneron Pharmaceuticals
10.1.1 Regeneron Pharmaceuticals Basic Information
10.1.2 Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.1.3 Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.1.4 Regeneron Pharmaceuticals Business Overview
10.1.5 Regeneron Pharmaceuticals SWOT Analysis
10.1.6 Regeneron Pharmaceuticals Recent Developments
10.2 Bayer HealthCare
10.2.1 Bayer HealthCare Basic Information
10.2.2 Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.2.3 Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.2.4 Bayer HealthCare Business Overview
10.2.5 Bayer HealthCare SWOT Analysis
10.2.6 Bayer HealthCare Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.3.3 Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.4.3 Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Kanghong Pharma
10.5.1 Kanghong Pharma Basic Information
10.5.2 Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.5.3 Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.5.4 Kanghong Pharma Business Overview
10.5.5 Kanghong Pharma Recent Developments
10.6 Merck
10.6.1 Merck Basic Information
10.6.2 Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.6.3 Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.6.4 Merck Business Overview
10.6.5 Merck Recent Developments
10.7 Allergan
10.7.1 Allergan Basic Information
10.7.2 Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.7.3 Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.7.4 Allergan Business Overview
10.7.5 Allergan Recent Developments
10.8 Santen Pharmaceutical
10.8.1 Santen Pharmaceutical Basic Information
10.8.2 Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.8.3 Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.8.4 Santen Pharmaceutical Business Overview
10.8.5 Santen Pharmaceutical Recent Developments
10.9 GlaxoSmithKline Pharmaceuticals
10.9.1 GlaxoSmithKline Pharmaceuticals Basic Information
10.9.2 GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.9.4 GlaxoSmithKline Pharmaceuticals Business Overview
10.9.5 GlaxoSmithKline Pharmaceuticals Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.10.3 Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Acucela
10.11.1 Acucela Basic Information
10.11.2 Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.11.3 Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.11.4 Acucela Business Overview
10.11.5 Acucela Recent Developments
10.12 Valent Pharmaceuticals
10.12.1 Valent Pharmaceuticals Basic Information
10.12.2 Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.12.3 Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.12.4 Valent Pharmaceuticals Business Overview
10.12.5 Valent Pharmaceuticals Recent Developments
10.13 IVERIC
10.13.1 IVERIC Basic Information
10.13.2 IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.13.3 IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.13.4 IVERIC Business Overview
10.13.5 IVERIC Recent Developments
11 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET FORECAST BY REGION
11.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast
11.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country
11.2.3 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region
11.2.4 South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Macular Degeneration (Amd) And Other Retinal Diseases by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2026-2035)
12.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2026-2035)
12.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Application (2026-2035)
12.2.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) Forecast by Application
12.2.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Macular Degeneration (Amd) And Other Retinal Diseases
1.2 Key Market Segments
1.2.1 Macular Degeneration (Amd) And Other Retinal Diseases Segment by Type
1.2.2 Macular Degeneration (Amd) And Other Retinal Diseases Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Product Life Cycle
3.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Manufacturers (2020-2025)
3.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Manufacturers (2020-2025)
3.5 Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Macular Degeneration (Amd) And Other Retinal Diseases Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Macular Degeneration (Amd) And Other Retinal Diseases Market Competitive Situation and Trends
3.8.1 Macular Degeneration (Amd) And Other Retinal Diseases Market Concentration Rate
3.8.2 Global 5 and 10 Largest Macular Degeneration (Amd) And Other Retinal Diseases Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES INDUSTRY CHAIN ANALYSIS
4.1 Macular Degeneration (Amd) And Other Retinal Diseases Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Macular Degeneration (Amd) And Other Retinal Diseases Market
5.7 ESG Ratings of Leading Companies
6 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Type (2020-2025)
6.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (2020-2025)
6.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Price by Type (2020-2025)
7 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Sales by Application (2020-2025)
7.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) by Application (2020-2025)
7.4 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
8 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET SALES BY REGION
8.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.1.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region
8.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.2.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.2.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.3 North America
8.3.1 North America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.3.2 North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.4.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.5.2 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country
8.6.2 South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region
8.7.2 Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET PRODUCTION BY REGION
9.1 Global Production of Macular Degeneration (Amd) And Other Retinal Diseases by Region(2020-2025)
9.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Region (2020-2025)
9.3 Global Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Macular Degeneration (Amd) And Other Retinal Diseases Production
9.4.1 North America Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.4.2 North America Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production
9.5.1 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.5.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (2020-2025)
9.6.1 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.6.2 Japan Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Macular Degeneration (Amd) And Other Retinal Diseases Production (2020-2025)
9.7.1 China Macular Degeneration (Amd) And Other Retinal Diseases Production Growth Rate (2020-2025)
9.7.2 China Macular Degeneration (Amd) And Other Retinal Diseases Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Regeneron Pharmaceuticals
10.1.1 Regeneron Pharmaceuticals Basic Information
10.1.2 Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.1.3 Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.1.4 Regeneron Pharmaceuticals Business Overview
10.1.5 Regeneron Pharmaceuticals SWOT Analysis
10.1.6 Regeneron Pharmaceuticals Recent Developments
10.2 Bayer HealthCare
10.2.1 Bayer HealthCare Basic Information
10.2.2 Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.2.3 Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.2.4 Bayer HealthCare Business Overview
10.2.5 Bayer HealthCare SWOT Analysis
10.2.6 Bayer HealthCare Recent Developments
10.3 Novartis
10.3.1 Novartis Basic Information
10.3.2 Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.3.3 Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.3.4 Novartis Business Overview
10.3.5 Novartis SWOT Analysis
10.3.6 Novartis Recent Developments
10.4 Roche
10.4.1 Roche Basic Information
10.4.2 Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.4.3 Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.4.4 Roche Business Overview
10.4.5 Roche Recent Developments
10.5 Kanghong Pharma
10.5.1 Kanghong Pharma Basic Information
10.5.2 Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.5.3 Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.5.4 Kanghong Pharma Business Overview
10.5.5 Kanghong Pharma Recent Developments
10.6 Merck
10.6.1 Merck Basic Information
10.6.2 Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.6.3 Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.6.4 Merck Business Overview
10.6.5 Merck Recent Developments
10.7 Allergan
10.7.1 Allergan Basic Information
10.7.2 Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.7.3 Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.7.4 Allergan Business Overview
10.7.5 Allergan Recent Developments
10.8 Santen Pharmaceutical
10.8.1 Santen Pharmaceutical Basic Information
10.8.2 Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.8.3 Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.8.4 Santen Pharmaceutical Business Overview
10.8.5 Santen Pharmaceutical Recent Developments
10.9 GlaxoSmithKline Pharmaceuticals
10.9.1 GlaxoSmithKline Pharmaceuticals Basic Information
10.9.2 GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.9.3 GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.9.4 GlaxoSmithKline Pharmaceuticals Business Overview
10.9.5 GlaxoSmithKline Pharmaceuticals Recent Developments
10.10 Pfizer
10.10.1 Pfizer Basic Information
10.10.2 Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.10.3 Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Acucela
10.11.1 Acucela Basic Information
10.11.2 Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.11.3 Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.11.4 Acucela Business Overview
10.11.5 Acucela Recent Developments
10.12 Valent Pharmaceuticals
10.12.1 Valent Pharmaceuticals Basic Information
10.12.2 Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.12.3 Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.12.4 Valent Pharmaceuticals Business Overview
10.12.5 Valent Pharmaceuticals Recent Developments
10.13 IVERIC
10.13.1 IVERIC Basic Information
10.13.2 IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
10.13.3 IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Market Performance
10.13.4 IVERIC Business Overview
10.13.5 IVERIC Recent Developments
11 MACULAR DEGENERATION (AMD) AND OTHER RETINAL DISEASES MARKET FORECAST BY REGION
11.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast
11.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country
11.2.3 Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region
11.2.4 South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Macular Degeneration (Amd) And Other Retinal Diseases by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2026-2035)
12.1.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2026-2035)
12.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Forecast by Application (2026-2035)
12.2.1 Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) Forecast by Application
12.2.2 Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (M USD)
Table 4. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application
Table 5. Macular Degeneration (Amd) And Other Retinal Diseases Market Size Comparison by Region (M USD)
Table 6. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration (Amd) And Other Retinal Diseases as of 2025)
Table 11. Global Market Macular Degeneration (Amd) And Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Macular Degeneration (Amd) And Other Retinal Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Macular Degeneration (Amd) And Other Retinal Diseases Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Type (K Units)
Table 27. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (M USD)
Table 28. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Type (2020-2025)
Table 29. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Type (2020-2025)
Table 30. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) by Type (2020-2025)
Table 31. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Type (2020-2025)
Table 32. Global Macular Degeneration (Amd) And Other Retinal Diseases Price (USD/Unit) by Type (2020-2025)
Table 33. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Application
Table 34. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application
Table 35. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Application (2020-2025) & (K Units)
Table 36. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application (2020-2025)
Table 37. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application (2020-2025) & (M USD)
Table 38. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application (2020-2025)
Table 39. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
Table 40. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 41. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region (2020-2025)
Table 42. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 43. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025)
Table 44. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 45. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 50. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 51. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 54. Global Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) by Region(2020-2025)
Table 55. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Region (2020-2025)
Table 57. Global Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Regeneron Pharmaceuticals Basic Information
Table 63. Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 64. Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Regeneron Pharmaceuticals Business Overview
Table 66. Regeneron Pharmaceuticals SWOT Analysis
Table 67. Regeneron Pharmaceuticals Recent Developments
Table 68. Bayer HealthCare Basic Information
Table 69. Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 70. Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bayer HealthCare Business Overview
Table 72. Bayer HealthCare SWOT Analysis
Table 73. Bayer HealthCare Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 76. Novartis Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 82. Roche Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Kanghong Pharma Basic Information
Table 86. Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 87. Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Kanghong Pharma Business Overview
Table 89. Kanghong Pharma Recent Developments
Table 90. Merck Basic Information
Table 91. Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 92. Merck Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Merck Business Overview
Table 94. Merck Recent Developments
Table 95. Allergan Basic Information
Table 96. Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 97. Allergan Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Allergan Business Overview
Table 99. Allergan Recent Developments
Table 100. Santen Pharmaceutical Basic Information
Table 101. Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 102. Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Santen Pharmaceutical Business Overview
Table 104. Santen Pharmaceutical Recent Developments
Table 105. GlaxoSmithKline Pharmaceuticals Basic Information
Table 106. GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 107. GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Pharmaceuticals Business Overview
Table 109. GlaxoSmithKline Pharmaceuticals Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 112. Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Acucela Basic Information
Table 116. Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 117. Acucela Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Acucela Business Overview
Table 119. Acucela Recent Developments
Table 120. Valent Pharmaceuticals Basic Information
Table 121. Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 122. Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Valent Pharmaceuticals Business Overview
Table 124. Valent Pharmaceuticals Recent Developments
Table 125. IVERIC Basic Information
Table 126. IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 127. IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. IVERIC Business Overview
Table 129. IVERIC Recent Developments
Table 130. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Macular Degeneration (Amd) And Other Retinal Diseases Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (M USD)
Table 4. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application
Table 5. Macular Degeneration (Amd) And Other Retinal Diseases Market Size Comparison by Region (M USD)
Table 6. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macular Degeneration (Amd) And Other Retinal Diseases as of 2025)
Table 11. Global Market Macular Degeneration (Amd) And Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Macular Degeneration (Amd) And Other Retinal Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Macular Degeneration (Amd) And Other Retinal Diseases Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Type (K Units)
Table 27. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Type (M USD)
Table 28. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Type (2020-2025)
Table 29. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Type (2020-2025)
Table 30. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) by Type (2020-2025)
Table 31. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Type (2020-2025)
Table 32. Global Macular Degeneration (Amd) And Other Retinal Diseases Price (USD/Unit) by Type (2020-2025)
Table 33. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) by Application
Table 34. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application
Table 35. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Application (2020-2025) & (K Units)
Table 36. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application (2020-2025)
Table 37. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Application (2020-2025) & (M USD)
Table 38. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application (2020-2025)
Table 39. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
Table 40. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 41. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region (2020-2025)
Table 42. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 43. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025)
Table 44. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 45. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 47. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 50. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales by Country (2020-2025) & (K Units)
Table 51. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025) & (M USD)
Table 54. Global Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) by Region(2020-2025)
Table 55. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Market Share by Region (2020-2025)
Table 57. Global Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Regeneron Pharmaceuticals Basic Information
Table 63. Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 64. Regeneron Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Regeneron Pharmaceuticals Business Overview
Table 66. Regeneron Pharmaceuticals SWOT Analysis
Table 67. Regeneron Pharmaceuticals Recent Developments
Table 68. Bayer HealthCare Basic Information
Table 69. Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 70. Bayer HealthCare Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Bayer HealthCare Business Overview
Table 72. Bayer HealthCare SWOT Analysis
Table 73. Bayer HealthCare Recent Developments
Table 74. Novartis Basic Information
Table 75. Novartis Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 76. Novartis Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Novartis Business Overview
Table 78. Novartis SWOT Analysis
Table 79. Novartis Recent Developments
Table 80. Roche Basic Information
Table 81. Roche Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 82. Roche Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Roche Business Overview
Table 84. Roche Recent Developments
Table 85. Kanghong Pharma Basic Information
Table 86. Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 87. Kanghong Pharma Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Kanghong Pharma Business Overview
Table 89. Kanghong Pharma Recent Developments
Table 90. Merck Basic Information
Table 91. Merck Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 92. Merck Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Merck Business Overview
Table 94. Merck Recent Developments
Table 95. Allergan Basic Information
Table 96. Allergan Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 97. Allergan Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Allergan Business Overview
Table 99. Allergan Recent Developments
Table 100. Santen Pharmaceutical Basic Information
Table 101. Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 102. Santen Pharmaceutical Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Santen Pharmaceutical Business Overview
Table 104. Santen Pharmaceutical Recent Developments
Table 105. GlaxoSmithKline Pharmaceuticals Basic Information
Table 106. GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 107. GlaxoSmithKline Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. GlaxoSmithKline Pharmaceuticals Business Overview
Table 109. GlaxoSmithKline Pharmaceuticals Recent Developments
Table 110. Pfizer Basic Information
Table 111. Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 112. Pfizer Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pfizer Business Overview
Table 114. Pfizer Recent Developments
Table 115. Acucela Basic Information
Table 116. Acucela Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 117. Acucela Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Acucela Business Overview
Table 119. Acucela Recent Developments
Table 120. Valent Pharmaceuticals Basic Information
Table 121. Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 122. Valent Pharmaceuticals Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Valent Pharmaceuticals Business Overview
Table 124. Valent Pharmaceuticals Recent Developments
Table 125. IVERIC Basic Information
Table 126. IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Product Overview
Table 127. IVERIC Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. IVERIC Business Overview
Table 129. IVERIC Recent Developments
Table 130. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Macular Degeneration (Amd) And Other Retinal Diseases Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Macular Degeneration (Amd) And Other Retinal Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD), 2025-2035
Figure 5. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) (2020-2035)
Figure 6. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Macular Degeneration (Amd) And Other Retinal Diseases Product Life Cycle
Figure 13. Macular Degeneration (Amd) And Other Retinal Diseases Sales Share by Manufacturers in 2025
Figure 14. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Share by Manufacturers in 2025
Figure 15. Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Macular Degeneration (Amd) And Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Macular Degeneration (Amd) And Other Retinal Diseases Revenue in 2025
Figure 18. Industry Chain Map of Macular Degeneration (Amd) And Other Retinal Diseases
Figure 19. Global Macular Degeneration (Amd) And Other Retinal Diseases Market PEST Analysis
Figure 20. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Type
Figure 27. Sales Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2020-2025)
Figure 28. Sales Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type in 2025
Figure 29. Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2020-2025)
Figure 30. Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application
Figure 33. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application (2020-2025)
Figure 34. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application in 2025
Figure 35. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application (2020-2025)
Figure 36. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application in 2025
Figure 37. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
Figure 38. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region (2020-2025)
Figure 39. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025)
Figure 40. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 43. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 45. U.S. Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Macular Degeneration (Amd) And Other Retinal Diseases Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Macular Degeneration (Amd) And Other Retinal Diseases Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 53. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 55. Germany Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region in 2024
Figure 67. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region in 2024
Figure 68. China Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 79. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 80. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (M USD)
Figure 81. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 82. Brazil Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region in 2024
Figure 92. Saudi Arabia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Macular Degeneration (Amd) And Other Retinal Diseases Production Market Share by Region (2020-2025)
Figure 103. North America Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 106. China Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share Forecast by Type (2026-2035)
Figure 111. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Application (2026-2035)
Figure 112. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Macular Degeneration (Amd) And Other Retinal Diseases
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD), 2025-2035
Figure 5. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) (2020-2035)
Figure 6. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Macular Degeneration (Amd) And Other Retinal Diseases Product Life Cycle
Figure 13. Macular Degeneration (Amd) And Other Retinal Diseases Sales Share by Manufacturers in 2025
Figure 14. Global Macular Degeneration (Amd) And Other Retinal Diseases Revenue Share by Manufacturers in 2025
Figure 15. Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Macular Degeneration (Amd) And Other Retinal Diseases Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Macular Degeneration (Amd) And Other Retinal Diseases Revenue in 2025
Figure 18. Industry Chain Map of Macular Degeneration (Amd) And Other Retinal Diseases
Figure 19. Global Macular Degeneration (Amd) And Other Retinal Diseases Market PEST Analysis
Figure 20. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Type
Figure 27. Sales Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2020-2025)
Figure 28. Sales Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type in 2025
Figure 29. Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type (2020-2025)
Figure 30. Market Share of Macular Degeneration (Amd) And Other Retinal Diseases by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application
Figure 33. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application (2020-2025)
Figure 34. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Application in 2025
Figure 35. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application (2020-2025)
Figure 36. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share by Application in 2025
Figure 37. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Growth Rate by Application (2020-2025)
Figure 38. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region (2020-2025)
Figure 39. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region (2020-2025)
Figure 40. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 43. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 45. U.S. Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Macular Degeneration (Amd) And Other Retinal Diseases Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Macular Degeneration (Amd) And Other Retinal Diseases Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Macular Degeneration (Amd) And Other Retinal Diseases Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Macular Degeneration (Amd) And Other Retinal Diseases Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 53. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 55. Germany Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region in 2024
Figure 67. Asia Pacific Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region in 2024
Figure 68. China Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 79. South America Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Country in 2024
Figure 80. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (M USD)
Figure 81. South America Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Country in 2024
Figure 82. Brazil Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size by Region in 2024
Figure 92. Saudi Arabia Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Macular Degeneration (Amd) And Other Retinal Diseases Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Macular Degeneration (Amd) And Other Retinal Diseases Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Macular Degeneration (Amd) And Other Retinal Diseases Production Market Share by Region (2020-2025)
Figure 103. North America Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 106. China Macular Degeneration (Amd) And Other Retinal Diseases Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share Forecast by Type (2026-2035)
Figure 111. Global Macular Degeneration (Amd) And Other Retinal Diseases Sales Forecast by Application (2026-2035)
Figure 112. Global Macular Degeneration (Amd) And Other Retinal Diseases Market Share Forecast by Application (2026-2035)
